Terms ending in 2038
Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,168,090 | SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINES AS RET KINASE INHIBITORS In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 11,851,434 | Substituted Pyrazolo[1,5-a]pyrazine Compounds as Ret Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 11,648,243 | Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 10,584,124 | Crystalline Forms In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 10,745,419 | Process for the Preparation of 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile In force · High confidence | Loxo Oncology, Inc. | In force | High confidence | |
| US 11,098,064 | Process for the Preparation of 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile In force · High confidence | Loxo Oncology, Inc. | In force | High confidence | |
| US 11,807,651 | Process for the Preparation of 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile In force · High confidence | Loxo Oncology, Inc. | In force | High confidence | |
| US 11,247,990 | Bicyclic Fused Pyridine Compounds as Inhibitors of Tam Kinases In force · High confidence | Array Biopharma Inc. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.